Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Knorr-Bremse Aktiengesellschaft: ​​​​​​​Knorr-Bremse Releases Annual Report and Announces Dividend Proposal
EQS-News: Knorr-Bremse Aktiengesellschaft: ​​​​​​​Knorr-Bremse Releases Annual Report and Announces Dividend Proposal
EQS-News: Knorr-Bremse Aktiengesellschaft: ​​​​​​​Knorr-Bremse Releases Annual Report and Announces Dividend Proposal
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-Adhoc: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-Adhoc: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-News: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-News: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-News: HENSOLDT AG: Oliver Dörre to succeed Thomas Müller in 2024 as Chairman of the Management Board as part of an early and long-term succession plan
EQS-News: Instone Real Estate Group SE achieves good result in a difficult environment with a largely stable earnings outlook for 2023
EQS-News: Instone Real Estate Group SE achieves good result in a difficult environment with a largely stable earnings outlook for 2023
EQS-News: Instone Real Estate Group SE achieves good result in a difficult environment with a largely stable earnings outlook for 2023
EQS-News: SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022
EQS-News: SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022
EQS-News: SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022
EQS-Adhoc: SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
EQS-Adhoc: SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
EQS-Adhoc: SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-Adhoc: SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share
EQS-Adhoc: SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share
EQS-Adhoc: SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share
EQS-Adhoc: New Work SE Executive Board proposes an increased regular dividend and payment of a special dividend
EQS-Adhoc: New Work SE Executive Board proposes an increased regular dividend and payment of a special dividend
EQS-Adhoc: New Work SE Executive Board proposes an increased regular dividend and payment of a special dividend
EQS-News: HENSOLDT grows significantly in 2022 financial year and stands ready as strong technology partner for the “Zeitenwende”
EQS-News: HENSOLDT grows significantly in 2022 financial year and stands ready as strong technology partner for the “Zeitenwende”
EQS-News: HENSOLDT grows significantly in 2022 financial year and stands ready as strong technology partner for the “Zeitenwende”
EQS-News: Knorr-Bremse Aktiengesellschaft: ​​​​​​​Knorr-Bremse Remains on the Path to Success Even in a Year of Global Crisis
EQS-News: Knorr-Bremse Aktiengesellschaft: ​​​​​​​Knorr-Bremse Remains on the Path to Success Even in a Year of Global Crisis
EQS-News: Knorr-Bremse Aktiengesellschaft: ​​​​​​​Knorr-Bremse Remains on the Path to Success Even in a Year of Global Crisis
EQS-News: SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing
EQS-News: SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing
EQS-News: SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing
EQS-Adhoc: SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes
EQS-Adhoc: SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes
EQS-Adhoc: SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes
EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment
EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment
EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: SYNLAB AG: Portuguese competition authority investigating the local laboratory diagnostics market – SYNLAB’s operations in Portugal included in such investigation
EQS-News: SYNLAB AG: Portuguese competition authority investigating the local laboratory diagnostics market – SYNLAB’s operations in Portugal included in such investigation
EQS-News: SYNLAB AG: Portuguese competition authority investigating the local laboratory diagnostics market – SYNLAB’s operations in Portugal included in such investigation
EQS-Adhoc: SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB
EQS-Adhoc: SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB
EQS-Adhoc: SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB
EQS-News: HENSOLDT AG accelerates growth and raises targets
EQS-News: HENSOLDT AG accelerates growth and raises targets
EQS-News: HENSOLDT AG accelerates growth and raises targets
EQS-News: DWS announces Strategic Ambition and Financial Targets for 2025
EQS-News: DWS announces Strategic Ambition and Financial Targets for 2025
EQS-News: DWS announces Strategic Ambition and Financial Targets for 2025
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Proposed dividend pay-out
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Proposed dividend pay-out
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Proposed dividend pay-out
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned